For 70 years, Evonik has been leveraging its market-leading expertise in oral excipients and related drug delivery technologies to help customers generate specific functionality outcomes for their small molecules and biologics. ... MORE

The highest load omega-3 powder ingredient in its class for dietary supplements ... MORE

As a CDMO expert we provide modern, established sites for LNP manufacturing and filling, as well as process technologies for CGMP manufacturing ... MORE

Evonik is a preferred CMO partner for APIs, HPAPIs and intermediates. Learn more about how our network, process expertise and upscaling capabilities support even the largest and most complex projects ... MORE

Our broad and flexible portfolio of drug delivery systems enables you to to optimize drug performance with superior targeting outcomes ... MORE

Our broad portfolio of parenteral drug delivery technologies, formulation development, manufacturing and filling services makes us your prefered CDMO for parenteral drug delivery. ... MORE

Many of the world’s largest and most innovative biopharmaceutical companies partner with Evonik to optimize their media platforms and processes. Our broad portfolio of cell culture ingredients and related services leverages six decades of industry leadership in highly purified amino acids. ... MORE

From optimized gastric resistance to enhanced bioavailability - EUDRACAP® leverages the functional versatility and safety of EUDRAGIT® to solve key challenges in oral drug delivery ... MORE

Evonik has won this year’s CPHI Excellence in Pharma Award in the category “Finished Formulation”. The winning innovation is EUDRACAP® colon – the first ready-to-fill, functional capsule on the market to target the ileo-colonic region. ... MORE

Launched last year, EUDRACAP® colon is the first functional, ready-to-fill capsule specifically designed to target the ileo-colonic region. ... MORE

Evonik and Ethris, a clinical-stage biotechnology company have entered into a strategic collaboration to develop and market a novel lipid nanoparticle (LNP) platform for nucleic acid delivery. ... MORE

The award recognizes Evonik’s strong cell culture ingredients portfolio that includes cQrex® peptides, the plant-based cholesterol PhytoChol®, as well as R&D, formulation and process expertise. ... MORE

Through the partnership, Evonik can provide customized nucleic acids from ST Pharm alongside its portfolio of lipid and lipid nanoparticle (LNP) drug product development services. ... MORE

Evonik is transforming its Health Care business to focus on its strategic core growth areas. ... MORE

In this interview, Colby Adolph explains the advantages of partnering with an experienced CDMO on a large-scale microbial fermentation project. ... MORE

In this article, Theresa Ledbetter discusses what made this acquisition successful, why there was an extremely high retention rate of staff at the acquired company and how the acquisition continues to benefit Evonik nearly 15 years on. ... MORE

In this interview, Whitney Moro and Tom Tice discuss what makes RESOMER® the most versatile polymeric excipient available on the market.  ... MORE

What is it like working with Evonik on a custom polymer project? In this article, Stefan Menzler takes you through three case studies where Evonik has worked with customers on tailored polymer projects.  ... MORE

By chemically coupling L-Tyrosine to glycine via a peptide bond, cQrex® GY delivers solubility that is up to 50 times higher than free L-Tyrosine at neutral pH. This means you can prepare concentrated feeds without the need to modify pH, reducing process complexity and risk. Plus, cQrex® GY is non-animal derived and chemically defined, making it a safe and reliable choice for your cell cultivation needs. Learn more in this article. ... MORE

In this interview, Eric Neuffer discusses the adoption of sustainable practices such as waste reduction, using renewable energy sources, adopting green energy principles, and investing in research and development of sustainable technologies. ... MORE